The FNB App of the Year Awards celebrated a showcase of solutions to real-world problems, writes ZIANDA GOLDSTUCK.

(Alliance News) - Hutchmed China Ltd on Monday said several of its oncology medicines will continue to be reimbursed under China's national insurance scheme next year, while one of its newer cancer ...

The poster presentation, titled “COMBAT-ALS Phase 2b/3 Trial of MN-166 (Ibudilast) in ALS: Trial Update and Basic Characteristics” (Reference # CTL-21), highlighted the following: Overview of the ...

Current and former employees at Jefferson City Correctional Center say the shortage is causing unrest. They blame the state’s ...

Ideally, you take blood pressure medication so that it’s most effective when your blood pressure is highest. Here’s how to figure that out.

HHSC attorneys are prohibited from giving legal advice to the public. HHSC staff, supervisors and other HHSC non-attorneys are prohibited from recommending specific actions to become eligible for ...

BEIJING -- The National Healthcare Security Administration said Monday that the coverage of China's basic medical insurance is stabilized at over 95 percent and that the quality of the system had ...

On Wednesday, providers from Highland Hospital made another donation to support global efforts to treat cystic fibrosis. Cystic fibrosis is a genetic condition that causes ...

While sudden cardiac arrest in a child or adolescent is rare—about 20,000 cases occur each year in the U.S.—the survival rate when it happens outside of a hospital is estimated to be under 20%.

BEIJING -- China has opted for a further expansion of its basic medical insurance portfolio through enriching its medical insurance drug catalog, increasing centralized medicine procurement, and ...

Click the link below to download a spreadsheet with an example Basic EPS (Cont. Ops) calculation for BeBetter Med Inc below: ...

Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...